 | • レポートコード：MRC2012A0545 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗うつ剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗うつ剤の種類別市場規模（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、選択的ノルアドレナリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、抗精神病薬、新規薬剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：H Lundbeck、Johnson & Johnson、Sun Pharmaceuticals、Astrazeneca、Bristol-Myers Squibb Company、Eli Lilly and Company、Sanofi、GlaxoSmithKline、Pfizer Inc.、Merck、 ・地域別グローバル市場分析 2015年-2020年 ・抗うつ剤の北米市場（アメリカ、カナダ、メキシコ） ・抗うつ剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗うつ剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗うつ剤の南米市場（ブラジル、アルゼンチン） ・抗うつ剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、選択的ノルアドレナリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、抗精神病薬、新規薬剤 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antidepressants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antidepressants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antidepressants market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antidepressants market has been segmented into
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents
By Application, Antidepressants has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antidepressants market presented in the report. This section sheds light on the sales growth of different regional and country-level Antidepressants markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antidepressants market.
The report offers in-depth assessment of the growth and other aspects of the Antidepressants market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antidepressants Market Share Analysis
Antidepressants competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antidepressants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antidepressants sales, revenue and market share for each player covered in this report.
The major players covered in Antidepressants are:
H Lundbeck
Johnson & Johnson
Sun Pharmaceuticals
Astrazeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
Sanofi
GlaxoSmithKline
Pfizer Inc.
Merck
Among other players domestic and global, Antidepressants market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antidepressants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antidepressants, with price, sales, revenue and global market share of Antidepressants in 2018 and 2019.
Chapter 3, the Antidepressants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antidepressants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antidepressants market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antidepressants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antidepressants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antidepressants Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tricyclic Antidepressants
1.2.3 Selective Serotonin Reuptake Inhibitors
1.2.4 Selective Norepinephrine Reuptake Inhibitors
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Benzodiazepines
1.2.7 Antipsychotics
1.2.8 Novel Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Antidepressants Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Antidepressants Market
1.4.1 Global Antidepressants Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 H Lundbeck
2.1.1 H Lundbeck Details
2.1.2 H Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 H Lundbeck SWOT Analysis
2.1.4 H Lundbeck Product and Services
2.1.5 H Lundbeck Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sun Pharmaceuticals SWOT Analysis
2.3.4 Sun Pharmaceuticals Product and Services
2.3.5 Sun Pharmaceuticals Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astrazeneca
2.4.1 Astrazeneca Details
2.4.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astrazeneca SWOT Analysis
2.4.4 Astrazeneca Product and Services
2.4.5 Astrazeneca Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb Company SWOT Analysis
2.5.4 Bristol-Myers Squibb Company Product and Services
2.5.5 Bristol-Myers Squibb Company Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly and Company SWOT Analysis
2.6.4 Eli Lilly and Company Product and Services
2.6.5 Eli Lilly and Company Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi SWOT Analysis
2.7.4 Sanofi Product and Services
2.7.5 Sanofi Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer Inc. SWOT Analysis
2.9.4 Pfizer Inc. Product and Services
2.9.5 Pfizer Inc. Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antidepressants Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antidepressants Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antidepressants Manufacturer Market Share in 2019
3.3.2 Top 6 Antidepressants Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antidepressants Sales, Revenue and Market Share by Regions
4.1.1 Global Antidepressants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antidepressants Revenue and Market Share by Regions (2015-2020)
4.2 North America Antidepressants Sales and Growth Rate (2015-2020)
4.3 Europe Antidepressants Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antidepressants Sales and Growth Rate (2015-2020)
4.5 South America Antidepressants Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antidepressants Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antidepressants Sales, Revenue and Market Share by Country
5.1.1 North America Antidepressants Sales and Market Share by Country (2015-2020)
5.1.2 North America Antidepressants Revenue and Market Share by Country (2015-2020)
5.2 United States Antidepressants Sales and Growth Rate (2015-2020)
5.3 Canada Antidepressants Sales and Growth Rate (2015-2020)
5.4 Mexico Antidepressants Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antidepressants Sales, Revenue and Market Share by Country
6.1.1 Europe Antidepressants Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antidepressants Revenue and Market Share by Country (2015-2020)
6.2 Germany Antidepressants Sales and Growth Rate (2015-2020)
6.3 UK Antidepressants Sales and Growth Rate (2015-2020)
6.4 France Antidepressants Sales and Growth Rate (2015-2020)
6.5 Russia Antidepressants Sales and Growth Rate (2015-2020)
6.6 Italy Antidepressants Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antidepressants Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antidepressants Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antidepressants Revenue and Market Share by Regions (2015-2020)
7.2 China Antidepressants Sales and Growth Rate (2015-2020)
7.3 Japan Antidepressants Sales and Growth Rate (2015-2020)
7.4 Korea Antidepressants Sales and Growth Rate (2015-2020)
7.5 India Antidepressants Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antidepressants Sales and Growth Rate (2015-2020)
7.7 Australia Antidepressants Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antidepressants Sales, Revenue and Market Share by Country
8.1.1 South America Antidepressants Sales and Market Share by Country (2015-2020)
8.1.2 South America Antidepressants Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antidepressants Sales and Growth Rate (2015-2020)
8.3 Argentina Antidepressants Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antidepressants Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antidepressants Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antidepressants Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antidepressants Sales and Growth Rate (2015-2020)
9.3 Turkey Antidepressants Sales and Growth Rate (2015-2020)
9.4 Egypt Antidepressants Sales and Growth Rate (2015-2020)
9.5 South Africa Antidepressants Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antidepressants Sales and Market Share by Type (2015-2020)
10.2 Global Antidepressants Revenue and Market Share by Type (2015-2020)
10.3 Global Antidepressants Price by Type (2015-2020)
11 Global Antidepressants Market Segment by Application
11.1 Global Antidepressants Sales Market Share by Application (2015-2020)
11.2 Global Antidepressants Revenue Market Share by Application (2015-2020)
11.3 Global Antidepressants Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antidepressants Sales, Revenue and Growth Rate (2021-2025)
12.2 Antidepressants Market Forecast by Regions (2021-2025)
12.2.1 North America Antidepressants Market Forecast (2021-2025)
12.2.2 Europe Antidepressants Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antidepressants Market Forecast (2021-2025)
12.2.4 South America Antidepressants Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antidepressants Market Forecast (2021-2025)
12.3 Antidepressants Market Forecast by Type (2021-2025)
12.3.1 Global Antidepressants Sales Forecast by Type (2021-2025)
12.3.2 Global Antidepressants Market Share Forecast by Type (2021-2025)
12.4 Antidepressants Market Forecast by Application (2021-2025)
12.4.1 Global Antidepressants Sales Forecast by Application (2021-2025)
12.4.2 Global Antidepressants Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antidepressants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antidepressants by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antidepressants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. H Lundbeck Basic Information, Manufacturing Base and Competitors
Table 8. H Lundbeck Antidepressants Major Business
Table 9. H Lundbeck Antidepressants Total Revenue (USD Million) (2018-2019)
Table 10. H Lundbeck SWOT Analysis
Table 11. H Lundbeck Antidepressants Product and Services
Table 12. H Lundbeck Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Antidepressants Major Business
Table 15. Johnson & Johnson Antidepressants Total Revenue (USD Million) (2018-2019)
Table 16. Johnson & Johnson SWOT Analysis
Table 17. Johnson & Johnson Antidepressants Product and Services
Table 18. Johnson & Johnson Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceuticals Antidepressants Major Business
Table 21. Sun Pharmaceuticals Antidepressants Total Revenue (USD Million) (2018-2019)
Table 22. Sun Pharmaceuticals SWOT Analysis
Table 23. Sun Pharmaceuticals Antidepressants Product and Services
Table 24. Sun Pharmaceuticals Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 26. Astrazeneca Antidepressants Major Business
Table 27. Astrazeneca Antidepressants Total Revenue (USD Million) (2018-2019)
Table 28. Astrazeneca SWOT Analysis
Table 29. Astrazeneca Antidepressants Product and Services
Table 30. Astrazeneca Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Company Antidepressants Major Business
Table 33. Bristol-Myers Squibb Company Antidepressants Total Revenue (USD Million) (2018-2019)
Table 34. Bristol-Myers Squibb Company SWOT Analysis
Table 35. Bristol-Myers Squibb Company Antidepressants Product and Services
Table 36. Bristol-Myers Squibb Company Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 38. Eli Lilly and Company Antidepressants Major Business
Table 39. Eli Lilly and Company Antidepressants Total Revenue (USD Million) (2018-2019)
Table 40. Eli Lilly and Company SWOT Analysis
Table 41. Eli Lilly and Company Antidepressants Product and Services
Table 42. Eli Lilly and Company Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Antidepressants Major Business
Table 45. Sanofi Antidepressants Total Revenue (USD Million) (2018-2019)
Table 46. Sanofi SWOT Analysis
Table 47. Sanofi Antidepressants Product and Services
Table 48. Sanofi Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Antidepressants Major Business
Table 51. GlaxoSmithKline Antidepressants Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Antidepressants Product and Services
Table 54. GlaxoSmithKline Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Inc. Antidepressants Major Business
Table 57. Pfizer Inc. Antidepressants Total Revenue (USD Million) (2018-2019)
Table 58. Pfizer Inc. SWOT Analysis
Table 59. Pfizer Inc. Antidepressants Product and Services
Table 60. Pfizer Inc. Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Antidepressants Major Business
Table 63. Merck Antidepressants Total Revenue (USD Million) (2018-2019)
Table 64. Merck SWOT Analysis
Table 65. Merck Antidepressants Product and Services
Table 66. Merck Antidepressants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Antidepressants Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Antidepressants Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Antidepressants Sales by Regions (2015-2020) (K Units)
Table 70. Global Antidepressants Sales Market Share by Regions (2015-2020)
Table 71. Global Antidepressants Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Antidepressants Sales by Countries (2015-2020) (K Units)
Table 73. North America Antidepressants Sales Market Share by Countries (2015-2020)
Table 74. North America Antidepressants Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Antidepressants Revenue Market Share by Countries (2015-2020)
Table 76. Europe Antidepressants Sales by Countries (2015-2020) (K Units)
Table 77. Europe Antidepressants Sales Market Share by Countries (2015-2020)
Table 78. Europe Antidepressants Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Antidepressants Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Antidepressants Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Antidepressants Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Antidepressants Sales by Countries (2015-2020) (K Units)
Table 83. South America Antidepressants Sales Market Share by Countries (2015-2020)
Table 84. South America Antidepressants Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Antidepressants Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Antidepressants Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Antidepressants Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Antidepressants Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Antidepressants Revenue Market Share by Countries (2015-2020)
Table 90. Global Antidepressants Sales by Type (2015-2020) (K Units)
Table 91. Global Antidepressants Sales Share by Type (2015-2020)
Table 92. Global Antidepressants Revenue by Type (2015-2020) (USD Million)
Table 93. Global Antidepressants Revenue Share by Type (2015-2020)
Table 94. Global Antidepressants Sales by Application (2015-2020) (K Units)
Table 95. Global Antidepressants Sales Share by Application (2015-2020)
Table 96. Global Antidepressants Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Antidepressants Market Share Forecast by Regions (2021-2025)
Table 98. Global Antidepressants Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Antidepressants Market Share Forecast by Type (2021-2025)
Table 100. Global Antidepressants Sales Forecast by Application (2021-2025)
Table 101. Global Antidepressants Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antidepressants Picture
Figure 2. Global Sales Market Share of Antidepressants by Type in 2019
Figure 3. Tricyclic Antidepressants Picture
Figure 4. Selective Serotonin Reuptake Inhibitors Picture
Figure 5. Selective Norepinephrine Reuptake Inhibitors Picture
Figure 6. Monoamine Oxidase Inhibitors Picture
Figure 7. Benzodiazepines Picture
Figure 8. Antipsychotics Picture
Figure 9. Novel Agents Picture
Figure 10. Antidepressants Sales Market Share by Application in 2018
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Antidepressants Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Antidepressants Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Antidepressants Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Antidepressants Sales Market Share by Manufacturer in 2019
Figure 35. Global Antidepressants Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Antidepressants Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Antidepressants Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Antidepressants Revenue Market Share by Regions (2015-2020)
Figure 42. Global Antidepressants Revenue Market Share by Regions in 2018
Figure 43. North America Antidepressants Sales and Growth Rate (2015-2020)
Figure 44. Europe Antidepressants Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Antidepressants Sales and Growth Rate (2015-2020)
Figure 46. South America Antidepressants Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Antidepressants Sales and Growth Rate (2015-2020)
Figure 48. North America Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Antidepressants Sales Market Share by Countries (2015-2020)
Figure 50. North America Antidepressants Sales Market Share by Countries in 2018
Figure 51. North America Antidepressants Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Antidepressants Revenue Market Share by Countries in 2018
Figure 53. United States Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Antidepressants Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Antidepressants Revenue Market Share by Countries in 2019
Figure 59. Germany Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Antidepressants Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Antidepressants Revenue Market Share by Regions 2019
Figure 67. China Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Antidepressants Sales Market Share by Countries in 2019
Figure 74. South America Antidepressants Revenue Market Share by Countries in 2019
Figure 75. Brazil Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Antidepressants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Antidepressants Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Antidepressants Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Antidepressants Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Antidepressants Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Antidepressants Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Antidepressants Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Antidepressants Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Antidepressants Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Antidepressants Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Antidepressants Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Antidepressants Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
うつ病性障害の世界市場（～2026年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…- 産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 抗うつ剤の世界市場（～2026年） Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…
- 慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
- 産後うつ病治療の世界市場（～2026年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Postpartum Depression Treatment Scope and Market Si…